Lisata Therapeutics (0HS8) Income Statement
Lisata Therapeutics Income Statement
Last quarter (Q2 2026), Lisata Therapeutics's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q2, Lisata Therapeutics's net income was $-2.93M. See Lisata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 170.00K | $ 1.00M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 24.00K | $ 1.00M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 18.23M | $ 23.41M | $ 25.71M | $ 57.60M | $ 29.05M | |
| Depreciation and Amortization | $ 146.00K | $ 174.00K | $ 189.00K | $ 69.00K | $ 55.00K |
| $ -17.40M | $ -20.61M | $ -22.98M | $ -56.63M | $ -28.92M | |
| $ -18.21M | $ -22.41M | $ -25.71M | $ -57.60M | $ -29.05M | |
| $ 661.00K | $ 1.63M | $ 2.54M | $ 897.00K | $ 76.00K | |
| $ -17.55M | $ -20.78M | $ -23.17M | $ -56.70M | $ -28.97M | |
| $ -16.59M | $ -19.98M | $ -20.84M | $ -54.23M | $ -27.47M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.91 | $ -2.40 | $ -2.58 | $ -10.47 | $ -7.45 |
| Diluted EPS | $ -1.91 | $ -2.40 | $ -2.58 | $ -10.47 | $ -7.45 |
| Weighted Average Shares Outstanding | 8.69M | 8.33M | 8.07M | 5.18M | 3.69M |
| Weighted Average Shares Outstanding (Diluted) | 8.69M | 8.33M | 8.07M | 5.18M | 3.69M |
Currency in USD
